In the Medtech POV Podcast’s most recent episode, Hologic President and CEO Steve MacMillan led host Scott Whitaker, President and CEO of AdvaMed, through a retrospective on the company’s more…
AdvaMedDx hosted an all-member educational session on the diagnostics regulatory reform bill, The VALID Act of 2021.
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
AdvaMedDx wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.
Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.
AdvaMedDx has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Advancing Diagnostics Together: In-Person & Virtual offerings with complete coverage of the most timely and important issues for the diagnostics industry.
The VALID Act marks a milestone in AdvaMedDx efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.